Skip to Main Content

COVID Resource Directory

Photo by Getty Images
Welcome to SalivaDirect’s COVID Resource Directory! This page includes valuable resources to help you navigate setting up (or continuing) your community’s COVID-19 response. Resources for each state (or US territory) include:
  • Labs you can partner with to offer testing
  • The latest on your state’s policies on testing, masking and vaccinations
  • Contacts for the federal funding opportunities you can use to help cover the costs.
Find details about your state below.

Wondering who to contact within the Operation Expanded Testing network to help with finding no-cost screening?

Those eligible include: Schools, underserved populations, and congregate settings such as homeless shelters, women’s shelters, prisons, and HBCUs. If you have questions on wether or not you qualify, reach out to the Coordination Hub for more information!
  • Hub 1: Colorado, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Montana, Nebraska, North Dakota, Ohio, South Dakota, Utah, Wisconsin, and Wyoming
  • Hub 2: Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Puerto Rico, Rhode Island, U.S. Virgin Islands, Vermont, Virginia, Washington D.C., and West Virginia
  • Hub 3: Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas

Information for states & U.S. territories

Looking for information specific to your state? Visit our partners at Open and Safe Schools – they host an interactive map, which includes state by state websites, government contacts, vendor lists, and information on funding.

Important Regulatory Information about SalivaDirect™

SalivaDirect™has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.